Pharmaceutical industry news

Monte Rosa Therapeutics: High-Stakes Drug Pipeline Balanced By A Fortress Balance Sheet

Kala Shankle on States, Timing and National Licensure Readiness

Safe Food a Shared Responsibility, Not Just FDA's Job, Says Tukaram Mundhe

Northwestern Medicine Bronzeville Outpatient Center Celebrates One Year of Providing High-Quality Care Closer to Home

Suven Life Sciences completes Phase 3 enrollment for Masupirdine in Alzheimer’s agitation

Mosquito Watch: submit a mosquito

If you have seen a mosquito in the UK, you can report it using the form on this page. You can also s...

Ultragenyx Pharmaceutical Inc. (RARE) Stock Price | Live Quotes & Charts | NASDAQ

Maharashtra FDA crackdown: 34,584 food samples taken up for testing between June and August, over 15,000 below standards

Low rents cost housing associations billions in investment capacity

New Data Confirms Innovative Pharmaceutical Industry is a Major Economic Engine for Canada

Maharashtra FDA steps up testing: Over 37,600 food, drug samples collected in three months; 15,268 found non-standard

A healthcare conference webcast is set for Sept. 10 in New York

Jyong Biotech Announces Participation in StockFan Virtual Investor Non-Deal Roadshow

Krystal Biotech to Participate in 2026 Cantor Global Healthcare Conference

Ultragenyx Pharmaceutical (NASDAQ:RARE) Lowered to Neutral Rating by JPMorgan Chase & Co.

Ultragenyx Pharmaceutical (NASDAQ:RARE) Rating Lowered to "Neutral" at Robert W. Baird

Ultragenyx Pharmaceutical (NASDAQ:RARE) Rating Lowered to "Equal Weight" at Wells Fargo & Company

Krystal Biotech to Present at 2026 Cantor Global Healthcare Conference

FIRST IN THE BALTICS: NORTHWAY BIOTECH OPENS €61 MILLION CELL THERAPY AND PERSONALIZED MEDICINE CDMO IN VILNIUS

Suven Life Sciences Completes 424-Patient Phase 3 Enrollment for Masupirdine in Alzheimer's Dementia...

Some of the Top Biotech Funds Just Bought Into This Under-the-Radar Biotech (NASDAQ: NVCT)

Billionaire family offices back healthcare and biotech startups in August

Pinpointing a Key Obstacle to Renewable CAR Macrophage Therapy

A plant-based drug developer will join a two-language online investor event Sept. 6

From his parents’ basement to your medicine cabinet: Absci CEO, College of Science alum Sean McClain endeavors to create biotech’s Apple

Priothera Appoints Experienced Biotech Executive, Dr Nigel

Priothera Appoints Experienced Biotech Executive, Dr Nigel Clark, as Chief Business Officer to Lead Strategic Partnering for Mocravimod

Clinical Research Site Community Selects 2026 SCRS Eagle Award Finalists

Ultragenyx's Angelman Syndrome Drug Fails Late-Stage Trial

GSK pens $1.3B Hutchmed deal for KRAS-EGFR cancer asset

Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer

WCG releases checklist to speed protocol amendment implementation at clinical trial sites

How Atlas Copco’s compliant, energy-efficient solutions keep pharmaceutical utilities performing at their best

William Blair Downgrades Ultragenyx Pharmaceutical to Market Perform From Outperform

Evercore ISI Downgrades Ultragenyx Pharmaceutical to In Line From Outperform, Adjusts Price Target to $16 From $34

Reading an FDA warning letter: record volumes, familiar failures

InvestingPro’s fair value model spotted Puma Biotech’s 95% rally By Investing.com

Fortrea’s $45M Early Phase Deal Sets a 90-Day Test for Sponsors With Active Studies

Ultragenyx’s apazunersen fails Phase 3 primary endpoint in Angelman syndrome

Predictive tools can confuse rare mutations with dangerous ones

Eledon Pharmaceuticals Announces Islet Cell Transplantation IND Submission, First Patients Enrolled in Multiple Transplant Programs, and Reaffirms Plan to Initiate Phase 3 Kidney Transplantation Trial in Fourth Quarter 2026

Ultragenyx fails phase 3 Angelman test, plots ‘significant expense reductions’

A Reminder: Smoking Still Causes Cancer

Insider Buys Additional CHF75k In Veraxa Biotech Stock

Federal Judge Pauses Case on Mifepristone Access Until After Midterm Elections

12 people with type 1 diabetes no longer needed insulin after transplants. Three more are joining.

Eledon Pharmaceuticals Announces Islet Cell Transplantation

Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule

Research team develops solvent-free tandem solar cells

Abivax has still not been acquired. What’s going on?

ERC Starting Grant für den Heidelberger Neurologen und Neurowissenschaftler Dr. Dr. Varun Venkataramani

Akeso's ivonescimab extends survival in PD-L1+ lung cancer

Regulating a Moving Target – FDA Seeks Comments on Possible Framework for Regulation of GenAI

New way to improve the effectiveness of antiangiogenic drugs and immunotherapy in breast cancer

HUTCHMED (China) signs licensing deal with GSK for experimental solid tumour drug

Last patient finishes 72-week MASH study for Inventiva (IVA)

What Does Resilience Mean in the European Forest? ERC Starting Grant for Research on the Future of European Forests

Heron Therapeutics stock trades at penny level as biotech focuses on pain and oncology pipeline

NHS injury costs recovery scheme: April 2026 to March 2027

Data on the funds collected by the Compensation Recovery Unit and funds paid to the NHS.

Russia attacks major pharmaceutical storage complex in Kyiv Oblast